Inflammatory bowel disease (IBD) involves interaction between host genetic factors and environmental triggers. CCDC88B maps within one IBD risk locus on human chromosome 11q13. Here we show that CCDC88B protein increases in the colon during intestinal injury, concomitant with an influx of CCDC88Blymphoid and myeloid cells. Loss of Ccdc88b protects against DSS-induced colitis, with fewer pathological lesions and reduced intestinal inflammation in Ccdc88b-deficient mice. In a T cell transfer model of colitis, Ccdc88b mutant CD4 T cells do not induce colitis in immunocompromised hosts. Expression of human CCDC88B RNA and protein is higher in IBD patient colons than in control colon tissue. In human CD14 myeloid cells, CCDC88B is regulated by cis-acting variants. In a cohort of patients with Crohn's disease, CCDC88B expression correlates positively with disease risk. These findings suggest that CCDC88B has a critical function in colon inflammation and the pathogenesis of IBD.Hook-related protein family member CCDC88b is encoded by a locus that has been associated with inflammatory bowel disease. Here the authors show that Ccdc88b inactivation in T cells prevents colitis in a transfer model, and detect high colonic levels of CCDC88b in patients with Crohn disease or ulcerative colitis, identifying that expression correlates with disease risk.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640600PMC
http://dx.doi.org/10.1038/s41467-017-01381-yDOI Listing

Publication Analysis

Top Keywords

ccdc88b
12
inflammatory bowel
12
bowel disease
12
myeloid cells
8
transfer model
8
expression correlates
8
disease risk
8
disease
7
colitis
5
ccdc88b required
4

Similar Publications

Genome-wide association studies of primary sclerosing cholangitis have identified 23 susceptibility loci. The majority of these loci reside in non-coding regions of the genome and are thought to exert their effect by perturbing the regulation of nearby genes. Here, we aim to identify these genes to improve the biological understanding of primary sclerosing cholangitis, and nominate potential drug targets.

View Article and Find Full Text PDF
Article Synopsis
  • Salivary gland adenoid cystic carcinoma (ACC), mucoepidermoid carcinoma (MEC), and oral squamous cell carcinoma (OSCC) are types of cancer in the head and neck, with previous treatments like immune checkpoint inhibitors failing in ACC.
  • The study investigated the effect of Gipie (CCDC88B), a protein that activates immune cells, by silencing it in cancer cell co-culture models and using various imaging and proteomic techniques.
  • Results showed that silencing Gipie in ACC cells led to increased cell death and activation of immune cells, suggesting that Gipie hinders anti-tumor immune responses in ACC but had little effect on other cancer types.
View Article and Find Full Text PDF

Modifiable risk factors and inflammation-related proteins in polymyalgia rheumatica: genome-wide meta-analysis and Mendelian randomisation.

Rheumatology (Oxford)

May 2024

Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Nobelsväg 13, 17177, Stockholm, Sweden.

Objective: Polymyalgia rheumatica (PMR) is an age-related inflammatory disease of unknown cause. We aimed to identify potentially modifiable risk factors and therapeutic targets for preventing or treating PMR.

Methods: We meta-analysed genetic association data from 8,156 cases of PMR (defined using diagnostic codes and self-report) and 416,495 controls of European ancestry from the UK Biobank and FinnGen.

View Article and Find Full Text PDF
Article Synopsis
  • - CCDC88B is linked to chronic inflammatory diseases and impacts dendritic cell (DC) migration in mice; disrupting this gene results in defective DC movement.
  • - Researchers found that the proteins ARHGEF2 and RASAL3 interact with CCDC88B and influence neuroinflammation and colitis susceptibility in mice with mutations in these proteins.
  • - The CCDC88B/RASAL3/ARHGEF2 complex regulates DC migration by affecting RHOA activation, with ARHGEF2 and RASAL3 having opposing effects on cell movement.
View Article and Find Full Text PDF

Identification of candidate DNA methylation biomarkers related to Alzheimer's disease risk by integrating genome and blood methylome data.

Transl Psychiatry

December 2023

Cancer Epidemiology Division, Population Sciences in the Pacific Program, University of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, HI, 96813, USA.

Alzheimer disease (AD) is a common neurodegenerative disease with a late onset. It is critical to identify novel blood-based DNA methylation biomarkers to better understand the extent of the molecular pathways affected in AD. Two sets of blood DNA methylation genetic prediction models developed using different reference panels and modelling strategies were leveraged to evaluate associations of genetically predicted DNA methylation levels with AD risk in 111,326 (46,828 proxy) cases and 677,663 controls.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!